Bohdan Waszkowycz
BioCity, Pennyfoot Street, U.K
Nottingham, ENG NG11GF, United Kingdom
Nottingham, ENG NG11GF, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Development of Structurally Simplified, Non-azadecalin Glucocorticoid Antagonists which Demonstrate In Vivo Activity.
Journal: Journal of medicinal chemistry
Published: April 07, 2026
Discovery and Optimization of wt-RET/KDR-Selective Inhibitors of RETV804M Kinase.
Journal: ACS medicinal chemistry letters
Published: December 17, 2019
Cell-Active Small Molecule Inhibitors of the DNA-Damage Repair Enzyme Poly(ADP-ribose) Glycohydrolase (PARG): Discovery and Optimization of Orally Bioavailable Quinazolinedione Sulfonamides.
Journal: Journal of medicinal chemistry
Published: November 08, 2018
Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia Cells.
Journal: Journal of medicinal chemistry
Published: December 23, 2016
First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib.
Journal: ACS chemical biology
Published: October 01, 2016
Identification of selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascade.
Journal: F1000Research
Published: July 19, 2016
Anilinoquinazoline inhibitors of the RET kinase domain-Elaboration of the 7-position.
Journal: Bioorganic & medicinal chemistry letters
Published: February 04, 2016
Application of virtual screening to the discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with potential for the treatment of cancer and axonopathies.
Journal: Bioorganic & medicinal chemistry letters
Published: February 02, 2016
The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity.
Journal: European journal of medicinal chemistry
Published: August 27, 2015
A reversed sulfonamide series of selective RORc inverse agonists.
Journal: Bioorganic & medicinal chemistry letters
Published: September 05, 2014
Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II.
Journal: Journal of medicinal chemistry
Published: July 18, 2013
Last Updated: 09/26/2026